SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisitions/Trading Update

13 Dec 2007 07:01

CVS Group plc13 December 2007 For Immediate Release 13 December 2007 CVS Group plc ("CVS" or "the Group") Acquisitions and Pre-close Trading Update Acquisitions CVS, one of the UK's leading providers of veterinary services, is pleased toannounce three single site practice acquisitions located in Kidsgrove inStaffordshire, Fleet in Hampshire and Doncaster. The practices achieved aggregate EBITDA of £276,000 on turnover of £1.986m fortheir respective latest financial reporting periods. The consideration, which isnot being disclosed for reasons of commercial sensitivity, is being satisfiedwholly in cash. The acquired practices employ a total of 10 vets bringing the Group total toalmost 300. Commenting on the acquisitions, CVS Chief Executive Simon Innes said "Each ofthese three practices enjoys a strong reputation for clinical care and we lookforward to developing an excellent long term relationship with their respectiveteams". Pre-close Trading Update With five months of the current financial year now behind us the Board isdelighted to report continued strong progress on all fronts. We started the financial year with 43 small animal practices operating from 120surgeries and with one equine specialist practice and three veterinarydiagnostic laboratories. In the period up to flotation in early October weacquired a further two small animal practices operating from seven surgerieswhich, together with the significant number of acquisitions made in the secondhalf of last financial year, gave us a substantially higher EBITDA run-rate thanthe actual historic EBITDA of £5.1m achieved for the year ended 30 June 2007. Since flotation we have acquired a further four small animal practices,including the three announced today, operating from six surgeries and employing24 vets. Our pipeline of potential acquisitions remains strong, assisted by thedemographics which have now been prevalent in the sector for a few years. We will remain focused on acquiring well established practices achievingexcellence in terms of clinical care and where each practice employs at leastthree vets. The central services provided by the Group remain very attractive tovets, enabling individual surgeries to focus on clinical care. Our organic growth continues to be firm and we are confident of achievinganother year of significant progress in executing our strategy. Contacts:CVS Group plc 01379 644 288Simon Innes, Chief ExecutivePaul Coxon, Finance Director Buchanan CommunicationsRichard Oldworth 0207 466 5000Suzanne Brocks 07776 234 600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20212:37 pmRNSBlock Listing Application
17th Dec 20211:41 pmRNSGrant of Options
15th Dec 202111:30 amRNSPDMR/PCA Dealings
13th Dec 20217:00 amRNSPDMR/PCA Dealings
7th Dec 202111:06 amRNSPDMR/PCA Dealings
30th Nov 20217:00 amRNSExercise of Options and Total Voting Rights
26th Nov 20215:31 pmRNSHolding(s) in Company
26th Nov 20215:24 pmRNSHolding(s) in Company
26th Nov 20218:16 amRNSGrant of Options & PDMR Dealing
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20213:09 pmRNSResult of AGM
24th Nov 20217:00 amRNSAGM Statement and Trading Update
19th Nov 20214:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.